Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JAGUAR HEALTH, INC.

(JAGX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Higher Ahead of Thursday Close

08/19/2021 | 04:05pm EDT


ę MT Newswires 2021
All news about JAGUAR HEALTH, INC.
10/07JAGUAR HEALTH : Provides Updates on Crofelemer and Lechlemer Development Pipeline as well ..
PU
09/30JAGUAR HEALTH : Founder and CEO Lisa Conte to Be Honored with Pure Earth Impact Award
PU
09/27JAGUAR HEALTH : Announces that Ladenburg Thalmann is Hosting R&D Showcase Webinar About Ca..
PU
09/24JAGUAR HEALTH : Receives 'Complete' Letter from FDA for Last of Four Major Technical Secti..
AQ
09/23JAGUAR HEALTH : Receives "Complete" Letter from FDA for Last of Four Major Technical Secti..
PU
09/20JAGUAR HEALTH, INC.(NASDAQCM : JAGX) added to S&P Global BMI Index
CI
09/17JAGUAR HEALTH : Participating investors include Jaguar CEO and CFO, Dragon SPAC S.p.A. spo..
PU
09/16REMINDER : Jaguar Health to Host Investor Webcast Monday, September 20th at 8:30 AM Easter..
PU
09/15JAGUAR HEALTH : Says European Medicines Agency Accepts for Review Its Orphan Drug Designat..
MT
09/15JAGUAR HEALTH : Orphan Drug Designation Application Submitted by Jaguar Health Subsidiary ..
PU
More news
Analyst Recommendations on JAGUAR HEALTH, INC.
More recommendations
Financials (USD)
Sales 2021 13,2 M - -
Net income 2021 -38,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 -3,02x
Yield 2021 -
Capitalization 92,6 M 92,6 M -
Capi. / Sales 2021 7,00x
Capi. / Sales 2022 3,70x
Nbr of Employees 34
Free-Float 88,3%
Chart JAGUAR HEALTH, INC.
Duration : Period :
Jaguar Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JAGUAR HEALTH, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 2,01 $
Average target price 14,00 $
Spread / Average Target 597%
EPS Revisions
Managers and Directors
Lisa A. Conte President, Chief Executive Officer & Director
Carol R. Lizak Chief Financial Officer
James J. Bochnowski Chairman
Pravin Ramsewak Chaturvedi Chief Scientific Officer
Jonathan S. Wolin Chief of Staff & Chief Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
JAGUAR HEALTH, INC.-17.79%93
GILEAD SCIENCES, INC.16.08%84 795
WUXI APPTEC CO., LTD.29.45%66 184
BIONTECH SE203.83%59 820
REGENERON PHARMACEUTICALS14.52%57 519
VERTEX PHARMACEUTICALS-23.09%47 156